Aethlon Medical Inc.
13F holders, Q3 2024 (September 30)19holders +1
6new positions
5sold out
$0.46avg. 13F price*
At the end of Q3 2024, 19 institutions reported holding Aethlon Medical Inc. in their 13F filings, up 1 from Q2 2024. 6 opened new positions and 5 sold out. The largest holders were UBS Group AG ($102K), Geode Capital Management, LLC ($46K) and Vanguard Group Inc. ($10K).
- Company
- Aethlon Medical Inc.
- CUSIP
- 00808Y406
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $9K |
| Exits | 5 | $37K |
All 13F filers, Q2 2024 → Q3 2024: 319,410 shares bought and 95,145 shares sold, net +224,265 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| UBS Group AG | 0.00% | Add +12515.8% | 218,253 | $102K |
| Geode Capital Management, LLC | 0.00% | Add +385.3% | 98,394 | $46K |
| Vanguard Group Inc. | 0.00% | Add +0.0% | 21,230 | $10K |
| Two Sigma Investments, LP | 0.00% | New | 15,436 | $7K |
| Two Sigma Securities, LLC | 0.00% | Reduce -60.2% | 13,738 | $6K |
| Baader Bank Aktiengesellschaft | 0.00% | Add +30.8% | 17,329 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +14.7% | 7,904 | $4K |
| BlackRock, Inc. | 0.00% | — | 7,340 | $3K |
| Citigroup Inc. | 0.00% | New | 2,487 | $1K |
| JPMorgan Chase & Co. | 0.00% | New | 1,646 | $768 |
| Group One Trading LLC | 0.00% | No change | 1,217 | $568 |
| Wells Fargo & Company | 0.00% | No change | 211 | $98 |
| Osaic Holdings, Inc. | 0.00% | Reduce -25.1% | 149 | $68 |
| Bank of America Corp. | 0.00% | Add +470.0% | 114 | $53 |
| Morgan Stanley | 0.00% | No change | 89 | $42 |
| Bartlett & Co. Wealth Management LLC | 0.00% | No change | 26 | $12 |
| Truvestments Capital LLC | 0.00% | New | 5 | $2 |
| Allworth Financial LP | 0.00% | New | 2 | $1 |
| Danske Bank A/S | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is AETHLON MEDICAL INC's weight in each manager's 13F, not the share of Aethlon Medical Inc. the manager owns.